Learn how we're pioneering a new wave of precision medicine, explore our collection of publications, disease studies, webinars, thought leadership, and more
Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis
New study provides the first detailed genetic insights into the mechanisms underpinning ME/CFS and offers new approaches for better diagnosis and treatments
A summary of how >70% of associated novel gene targets for severe COVID-19 identified with combinatorial analytics in May 2020 have now been independently validated
Complexity of Disease Biology Gives Opportunities for Drug Discovery
In this article, Dr Steve Gardner, CEO PrecisionLife, examines the lack of return on investment for pharmaceutical R&D and the huge pockets of unmet medical need in common chronic disorders
